The motor effects of bromocriptine--a review (Q39608215)

13 September 2017

1 reference

title

The motor effects of bromocriptine--a review (English)

1 reference

13 September 2017

D M Jackson

1

1 reference

13 September 2017

O F Jenkins

series ordinal

2

1 reference

13 September 2017

S B Ross

series ordinal

3

1 reference

13 September 2017

publication date

1 January 1988

1 reference

13 September 2017

1 reference

13 September 2017

volume

95

1 reference

13 September 2017

issue

4

1 reference

13 September 2017

page(s)

433-446

1 reference

Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine

13 September 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine, Lergotrile: The Antiparkinsonian Efficacy and the Interaction with Monoaminergic Receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopaminergic and non-dopaminergic neurons in substantia nigra: differential response to bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The antiparkinsonian efficacy of bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Further functional in vitro comparison of pre- and postsynaptic dopamine receptors in the rabbit caudate nucleus

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine for levodopa-induced end-of-dose dystonia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Ergot Alkaloids and Cyclic Nucleotides in the CNS

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effect of dopamine agonists and neuroleptic agents on striatal acetylcholine transmission in the rat: evidence against dopamine receptor multiplicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Differential effects of three dopamine agonists: apomorphine, bromocriptine and lergotrile

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine, dihydroergotoxine, methysergide, d-LSD, CF 25-397, and 29-712: Effects on the metabolism of the biogenic amines in the brain of the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Catalepsy induced by SCH 23390 in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Regulation of striatal acetylcholine concentration by D2-dopamine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Pharmacological characterization of the D2 dopamine receptor negatively coupled with adenylate cyclase in rat anterior pituitary

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Microelectrophoretic studies with 2-bromo-alpha-ergocriptine on dopaminergic neurons in the feline caudate nucleus

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

D-1 dopamine receptor stimulation potentiates neurophysiological effects of bromocriptine in rats with lesions of the nigrostriatal dopamine pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Evidence for an irreversible interaction of bromocryptine with central dopamine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine enhances the behavioural effects of apomorphine and dopamine after systemic or intracerebral injection in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Restoration of locomotor activity in mice by low L-DOPA doses after suppression by alpha-methyltyrosine but not by reserpine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Pharmacological difference of L-dopa, apomorphine, and bromocriptine against metoclopramide

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine ?Autoreceptors?: Pharmacological characterization by microiontophoretic single cell recording studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The interactions of bromocriptine and lergotrile with dopamine and α-adrenergic receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Differential inhibition by dopamine D-1 and D-2 antagonists of circling behaviour induced by dopamine agonists in rats with unilateral 6-hydroxydopamine lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Characterization of normal and supersensitive dopamine receptors: Effects of ergot drugs and neuropeptides

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Ergot and catecholamine potencies at catecholamine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Evidence for selective and long-lasting stimulation of “regulatory” dopamine-receptors by bromocriptine (CB 154)

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Pharmacological evidence against the involvement of the D1 subtype of dopamine receptors in apomorphine-induced hypothermia

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Metabolite involvement in the behavioral effects of bromocriptine in cats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Multiple receptors for dopamine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine-mediated behaviours produced in naive mice by bromocriptine plus SKF 38393

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Noradrenaline-sensitive adenylate cyclase in slices of mouse limbic forebrain: characterisation and effect of dopaminergic agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Endogenous dopamine release from rat striatal slices and its regulation by D-2 autoreceptors: effects of uptake inhibitors and synthesis inhibition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine-like effects of cholera toxin in the central nervous system

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Increase in rat striatal acetylcholine content by bromocriptine: evidence for an indirect dopaminergic action

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine and levodopa (with or without carbidopa) in parkinsonism

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

A comparison between amantadine and bromocriptine using the stereotyped behaviour response test (SBR) in the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Subsensitivity of the rat striatal dopaminergic system after treatment with bromocriptine: effects on [3H]spiperone binding and dopamine-stimulated cyclic AMP formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Ergot alkaloids as dopamine agonists: comparison in two rodent models

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Repeated electroconvulsive shock increases the behavioural responses of rats to injection of both dopamine and dibutyryl cyclic amp into the nucleus accumbens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopaminephilic properties of ergot alkaloids

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effects of ergot drugs on serotonergic function: Behavior and neurochemistry

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Neurochemical effects of some ergot derivatives: A basis for their antiparkinson actions

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Biochemical aspects of dopamine agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

SCH23390 effects on apomorphine-induced responses of nigral dopaminergic neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Regional in vivo binding of [3H]N-propylnorapomorphine in the mouse brain. Evidence for labelling of central dopamine receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effects of bromocriptine on 3H-spiroperidol binding sites in rat striatum. Evidence for actions of dopamine receptors not linked to adenylate cyclase

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The roles of presynaptic function and hepatic drug metabolism in the hypothermic actions of two novel dopaminergic agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Differential effects of bromocriptine on dopamine and acetylcholine release modulatory receptors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The central effects of a novel dopamine agonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

https://pubmed.ncbi.nlm.nih.gov/3145515

1 reference

12 December 2020

Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Binding characteristics of a radiolabeled agonist and antagonist at central nervous system alpha noradrenergic receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

SCH 23390—The first selective dopamine D-1 antagonist

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopaminergic mechanisms and motor function: characterization of D-1 and D-2 dopamine receptor interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effect of haloperidol pre- and post-treatment on the ability of pergolide and bromocriptine to antagonize the gamma-butyrolactone-induced increase in brain dopamine in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Mesolimbic dopaminergic neurones in the rotational model of nigrostriatal function

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Binding of dopamine to bovine anterior pituitary gland membranes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

3H-spiroperidol labels dopamine receptors in pituitary and brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Ergot alkaloids: interaction with presynaptic dopamine receptors in the neostriatum and olfactory tubercles

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptin and methylergometrine : Pharmacological approach of the mechanism of their central effects

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Resumption of prolactin secretion after dopaminergic inhibition: differential effects of dopamine and its agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Binding of antiparkinsonian ergot derivatives to the dopamine receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine induces marked locomotor stimulation in dopamine-depleted mice when D-1 dopamine receptors are stimulated with SKF38393

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Lack of effect of bromocriptine on the activity of monoamine oxidase in rat brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Inhibition of neurotransmitter receptor binding by ergot derivatives

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The selectivity of some ergot derivatives for α1 and α2-adrenoceptors of rat cerebral cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

A pharmacological comparison of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99) and N-n-propyl-3-(3-hydroxyphenyl)piperidine with (3-PPP) selected dopamine agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The effect of bromocriptine on locomotor activity and cerebral catecholamines in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

[3H]Sulpiride, a ligand for neuroleptic receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Direct evidence for the stimulation of rabbit retina dopamine receptors by ergot alkaloids

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Metabolite involvement in bromocriptine-induced circling behaviour in rodents

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Further investigations on the effects of ergometrine and other ergot derivatives following injection into the nucleus accumbens of the rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Ergometrine induced locomotor activity following intracerebral injection into the nucleus accumbens

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microiontophoretic studies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

D-1 and D-2 dopamine receptor blockade: interactive effects in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Effect of ergot drugs on central 5-hydroxytryptamine neurons: evidence for 5-hydroxytryptamine release or 5-hydroxytryptamine receptor stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Evidence for in vivo binding of apomorphine and bromocriptine to receptor sites not labelled by 3H-spiperone

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Bromocriptine and dopamine-receptor stimulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Inhibition of apomorphine-, bromocriptine- and lergotrile-induced circling behaviour in rats by subsequent haloperidol administration

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Non-opiate $beta;-endorphin fragments and dopamine?VI Behavioural analysis of the interaction between $gamma;-type endorphins and dopaminergic systems in the nucleus accumbens of rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Stimulation of 3H-apomorphine binding by dopamine and bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Properties of [3H]haloperidol and [3H]dopamine binding associated with dopamine receptors in calf brain membranes

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Dopamine receptor binding regulated by guanine nucleotides

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Correlation of behavioural inhibition or excitation produced by bromocriptine with changes in brain catecholamine turnover

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Further studies on the interaction between bromocriptine and SKF38393 in reserpine and alpha methyl-para-tyrosine-treated mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3145515

12 December 2020

Identifiers

DOI

10.1007/BF00172952

1 reference

13 September 2017

1 reference